Because HER2 clearly has an important role in prognosis after a diagnosis of breast cancer, the gene encoding it is a natural target for investigation regarding polymorphisms that might indicate resistance or susceptibility for breast cancer development. The gene discussed is ERBB2; the disease is breast cancer.